WO2007062874B1 - Sulfamoylsulfonat-prodrugs - Google Patents
Sulfamoylsulfonat-prodrugsInfo
- Publication number
- WO2007062874B1 WO2007062874B1 PCT/EP2006/011726 EP2006011726W WO2007062874B1 WO 2007062874 B1 WO2007062874 B1 WO 2007062874B1 EP 2006011726 W EP2006011726 W EP 2006011726W WO 2007062874 B1 WO2007062874 B1 WO 2007062874B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- quinine
- sulfonate
- sulfamoylphenyl
- triene
- prodrugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06829354A EP1957513A2 (de) | 2005-11-30 | 2006-11-27 | Sulfamoylsulfonat-prodrugs |
CA002632272A CA2632272A1 (en) | 2005-11-30 | 2006-11-27 | Sulfamoyl sulfonate prodrugs |
JP2008542678A JP2009517424A (ja) | 2005-11-30 | 2006-11-27 | スルファモイルスルホネートプロドラッグ |
BRPI0619253-0A BRPI0619253A2 (pt) | 2005-11-30 | 2006-11-27 | pró-fármacos de sulfonato de sulfamoìla |
EA200801306A EA200801306A1 (ru) | 2005-11-30 | 2006-11-27 | Сульфамоилсульфонатные пролекарства |
AU2006319380A AU2006319380A1 (en) | 2005-11-30 | 2006-11-27 | Sulfamoyl sulfonate prodrugs |
IL191570A IL191570A0 (en) | 2005-11-30 | 2008-05-20 | Sulfamoyl sulfonate prodrugs |
NO20082915A NO20082915L (no) | 2005-11-30 | 2008-06-27 | Sulfamoylsulfonat-prodrug |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005057408.4 | 2005-11-30 | ||
DE102005057408A DE102005057408A1 (de) | 2005-11-30 | 2005-11-30 | Sulfamoylsulfonat-Prodrugs |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2007062874A2 WO2007062874A2 (de) | 2007-06-07 |
WO2007062874A3 WO2007062874A3 (de) | 2007-07-12 |
WO2007062874B1 true WO2007062874B1 (de) | 2007-09-27 |
Family
ID=37983623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/011726 WO2007062874A2 (de) | 2005-11-30 | 2006-11-27 | Sulfamoylsulfonat-prodrugs |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1957513A2 (de) |
JP (1) | JP2009517424A (de) |
KR (1) | KR20080072956A (de) |
CN (1) | CN101316858A (de) |
AU (1) | AU2006319380A1 (de) |
BR (1) | BRPI0619253A2 (de) |
CA (1) | CA2632272A1 (de) |
CR (1) | CR10003A (de) |
DE (1) | DE102005057408A1 (de) |
EA (1) | EA200801306A1 (de) |
EC (1) | ECSP088489A (de) |
IL (1) | IL191570A0 (de) |
NO (1) | NO20082915L (de) |
WO (1) | WO2007062874A2 (de) |
ZA (1) | ZA200805659B (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010110747A1 (en) * | 2009-03-24 | 2010-09-30 | National University Of Singapore | Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (copd) |
CN101987104A (zh) * | 2009-08-05 | 2011-03-23 | 天津金耀集团有限公司 | 一种杂芳香基氨磺酰基羧酸酯碳酸酐酶抑制剂的眼用组合物 |
CN101987101A (zh) * | 2009-08-05 | 2011-03-23 | 天津金耀集团有限公司 | 糖皮质激素芳香基氨磺酰基磺酸酯为活性成分的眼用抗炎组合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10027887A1 (de) * | 2000-05-31 | 2001-12-13 | Jenapharm Gmbh | Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
DE102004025985A1 (de) * | 2004-05-21 | 2005-12-15 | Schering Ag | Estriol- und Estetrol-Prodrugs |
DE102004025986A1 (de) * | 2004-05-21 | 2005-12-15 | Schering Ag | Steroid-Prodrugs mit androgener Wirkung |
DE102004025966A1 (de) * | 2004-05-21 | 2005-12-15 | Schering Ag | Estradiol-Prodrugs |
-
2005
- 2005-11-30 DE DE102005057408A patent/DE102005057408A1/de not_active Ceased
-
2006
- 2006-11-27 EA EA200801306A patent/EA200801306A1/xx unknown
- 2006-11-27 EP EP06829354A patent/EP1957513A2/de not_active Withdrawn
- 2006-11-27 CN CNA2006800449086A patent/CN101316858A/zh active Pending
- 2006-11-27 CA CA002632272A patent/CA2632272A1/en not_active Abandoned
- 2006-11-27 KR KR1020087015775A patent/KR20080072956A/ko not_active Application Discontinuation
- 2006-11-27 BR BRPI0619253-0A patent/BRPI0619253A2/pt not_active Application Discontinuation
- 2006-11-27 AU AU2006319380A patent/AU2006319380A1/en not_active Abandoned
- 2006-11-27 WO PCT/EP2006/011726 patent/WO2007062874A2/de active Application Filing
- 2006-11-27 JP JP2008542678A patent/JP2009517424A/ja active Pending
-
2008
- 2008-05-20 IL IL191570A patent/IL191570A0/en unknown
- 2008-05-21 CR CR10003A patent/CR10003A/es not_active Application Discontinuation
- 2008-05-30 EC EC2008008489A patent/ECSP088489A/es unknown
- 2008-06-27 NO NO20082915A patent/NO20082915L/no not_active Application Discontinuation
- 2008-06-27 ZA ZA200805659A patent/ZA200805659B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200805659B (en) | 2009-10-28 |
EA200801306A1 (ru) | 2008-10-30 |
WO2007062874A3 (de) | 2007-07-12 |
KR20080072956A (ko) | 2008-08-07 |
WO2007062874A2 (de) | 2007-06-07 |
DE102005057408A1 (de) | 2007-05-31 |
CR10003A (es) | 2008-08-21 |
EP1957513A2 (de) | 2008-08-20 |
BRPI0619253A2 (pt) | 2011-09-27 |
CN101316858A (zh) | 2008-12-03 |
AU2006319380A1 (en) | 2007-06-07 |
CA2632272A1 (en) | 2007-06-07 |
IL191570A0 (en) | 2008-12-29 |
JP2009517424A (ja) | 2009-04-30 |
NO20082915L (no) | 2008-06-27 |
ECSP088489A (es) | 2008-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2456781B1 (de) | 17-hydroxy-17-pentafluorethyl-estra-4,9 (10)-dien-11-acyloxyalkylenphenyl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten | |
EP3252069B1 (de) | (11.beta.,17.beta.)-17-hydroxy-11-[4-(methylsulfonyl)phenyl]-17-(pentalfuoromethyl)estra-4,9-dien-3-one zur behandlung von krankheiten | |
EP2456779B1 (de) | 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten | |
EP1448591B1 (de) | 17alpha-alkyl-17beta-oxy-estratriene und zwischenprodukte zu deren herstellung, verwendung der 17alpha-alkyl-17beta-oxy-estratriene zur herstellung von arzneimitteln sowie pharmazeutische präparate | |
US6388109B1 (en) | 14,15-cyclopropano steroids of the 19-norandrostane series, method for the production thereof and pharmaceutical preparations containing said compounds | |
EP0970104A2 (de) | Steroidsulfamate, verfahren zu ihrer herstellung und anwendung derselben | |
DE3506785A1 (de) | 11ss-n,n-dimethylaminophenyl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate | |
WO2007062874B1 (de) | Sulfamoylsulfonat-prodrugs | |
WO2005113575A1 (de) | Steroid-prodrugs mit androgener wirkung | |
US20060009434A1 (en) | New 2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17beta-hydroxy steroid dehydrogenase type 1 | |
DE102004032674A1 (de) | Neue 2-substituierte Estra-1,3,5(10)-trien-17-one als Inhibitoren der 17β-Hydroxysteroiddehydrogenase Typ 1 | |
DE10307104A1 (de) | Antitumor wirksame 2-substituierte Estra-1,3,5(10)-trien-3-yl sulfamate | |
ZA200306537B (en) | Androgenic 7-substituted 11-halogen steroids. | |
EP1959964A1 (de) | Heteroaromatische sulfonamid-prodrugs | |
EP1737880B1 (de) | 17 alpha-fluor 17 beta-hydroximinomethyl-steroide, ein verfahren zu deren herstellung und diese verbindung enthaltende pharmazeutische zusammensetzungen | |
DE69815329T2 (de) | Estra-5(10),7-diene mit östrogener aktivität | |
DE102005059222B4 (de) | 11ß-Benzaldoximderivate von D-Homoestra-4,9-dien-3-onen | |
DE60131253T2 (de) | 6-oxygenierte steroid-estrogene mit aromatischen a- und b-ringen | |
EP1622924A2 (de) | 8beta-vinyl-11beta-(omega-substituierte)alkyl-estra-1,3,5(10)-triene | |
DE102005057224A1 (de) | Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen | |
DE102005057225A1 (de) | Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen | |
DE10151114A1 (de) | 8ß-Substituierte-11ß-aryl-estra-2,3,5(10)-trienderivate | |
CZ20004566A3 (cs) | Nové sloučeniny, jejich použití, způsob regulace meiózy a nový znak |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680044908.6 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 191570 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006829354 Country of ref document: EP Ref document number: CR2008-010003 Country of ref document: CR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 4338/DELNP/2008 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2632272 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 568620 Country of ref document: NZ Ref document number: 2008050874 Country of ref document: EG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008542678 Country of ref document: JP Ref document number: 12008501284 Country of ref document: PH Ref document number: 08054911 Country of ref document: CO |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2008/007038 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200801306 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020087015775 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006319380 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2006319380 Country of ref document: AU Date of ref document: 20061127 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2006319380 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2006829354 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0619253 Country of ref document: BR Kind code of ref document: A2 Effective date: 20080530 |